Cargando…

SARS-CoV-2 vaccine safe for young patients

Detalles Bibliográficos
Autor principal: Onuora, Sarah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9366756/
https://www.ncbi.nlm.nih.gov/pubmed/35953559
http://dx.doi.org/10.1038/s41584-022-00831-2
_version_ 1784765637208309760
author Onuora, Sarah
author_facet Onuora, Sarah
author_sort Onuora, Sarah
collection PubMed
description
format Online
Article
Text
id pubmed-9366756
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-93667562022-08-11 SARS-CoV-2 vaccine safe for young patients Onuora, Sarah Nat Rev Rheumatol In Brief Nature Publishing Group UK 2022-08-11 2022 /pmc/articles/PMC9366756/ /pubmed/35953559 http://dx.doi.org/10.1038/s41584-022-00831-2 Text en © Springer Nature Limited 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle In Brief
Onuora, Sarah
SARS-CoV-2 vaccine safe for young patients
title SARS-CoV-2 vaccine safe for young patients
title_full SARS-CoV-2 vaccine safe for young patients
title_fullStr SARS-CoV-2 vaccine safe for young patients
title_full_unstemmed SARS-CoV-2 vaccine safe for young patients
title_short SARS-CoV-2 vaccine safe for young patients
title_sort sars-cov-2 vaccine safe for young patients
topic In Brief
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9366756/
https://www.ncbi.nlm.nih.gov/pubmed/35953559
http://dx.doi.org/10.1038/s41584-022-00831-2
work_keys_str_mv AT onuorasarah sarscov2vaccinesafeforyoungpatients